Evaluation of an interferon-gamma release assay in young contacts of active tuberculosis cases
AbstractIn a cross-sectional study in a hospital in Tehran in 2006-08 the QuantiFERON[Registered]-TB interferon-gamma release assay [QTB] was compared with the tuberculin skin test [TST] in 59 young people [aged<20 years] with close contact with immunocompetent cases of proven pulmonary tuberculosis. After 1 year follow-up 10 subjects had progressed to tuberculosis disease and received treatment; TST was positive in 30% and QTB in 100%. Of the 49 non-progressive subjects, TST was positive in 10.4% and QTB in 16.3%. The agreement between TST and QTB assay in non-progressive subjects was poor [Kappa=0.43]. False positive and false negative rates for TST were 40.0% and 9.3% respectively; positive and predictive values were 60.0% and 90.7%. We suggest adding the interferon assay to the skin test in the decision to perform chest X-ray or to start chemoprophylaxis at least in younger subjects [aged<20 years]
Noorbakhsh, S., Mousavi, J., Barati, M., Shamshiri, A.R., Shekarabi, M. et al. (2011). Evaluation of an interferon-gamma release assay in young contacts of active tuberculosis cases. EMHJ - Eastern Mediterranean Health Journal, 17 (9), 714-718, 2011 http://www.who.int/iris/handle/10665/118146
JournalEMHJ - Eastern Mediterranean Health Journal, 17 (9), 714-718, 2011
MetadataShow full item record
Showing items related by title and MeSH subject.
Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifampicin resistance in adults and children : expert group meeting report : 2013 World Health Organization (WHO/HTM/TB/2013.14, 2013)
Technique automatisée d’amplification de l’acide nucléique en temps réel pour la détection rapide et simultanée de la tuberculose et de la résistance à la rifampicine : système Xpert MTB/RIF : déclaration de principe Organisation mondiale de la Santé (WHO/HTM/TB/2011.4, 2011)